Geode Capital Management’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Sell |
76,095
-13,180
| -15% | -$21K | ﹤0.01% | 4014 |
|
|
2025
Q1 | $133K | Buy |
89,275
+12,769
| +17% | +$19K | ﹤0.01% | 3950 |
|
|
2024
Q4 | $306K | Sell |
76,506
-1,802,447
| -96% | -$7.21M | ﹤0.01% | 3754 |
|
|
2024
Q3 | $941K | Buy |
1,878,953
+232,656
| +14% | +$116K | ﹤0.01% | 3373 |
|
|
2024
Q2 | $961K | Sell |
1,646,297
-1,299,197
| -44% | -$759K | ﹤0.01% | 3321 |
|
|
2024
Q1 | $2.64M | Buy |
2,945,494
+165,586
| +6% | +$149K | ﹤0.01% | 3010 |
|
|
2023
Q4 | $2.1M | Buy |
2,779,908
+104,533
| +4% | +$79.1K | ﹤0.01% | 3085 |
|
|
2023
Q3 | $1.83M | Buy |
2,675,375
+67,342
| +3% | +$46.1K | ﹤0.01% | 3099 |
|
|
2023
Q2 | $3.13M | Buy |
2,608,033
+1,269,256
| +95% | +$1.52M | ﹤0.01% | 2947 |
|
|
2023
Q1 | $1.57M | Buy |
1,338,777
+6,154
| +0.5% | +$7.2K | ﹤0.01% | 3133 |
|
|
2022
Q4 | $1.05M | Buy |
1,332,623
+9,327
| +0.7% | +$7.36K | ﹤0.01% | 3316 |
|
|
2022
Q3 | $1.6M | Buy |
1,323,296
+13,237
| +1% | +$16K | ﹤0.01% | 3163 |
|
|
2022
Q2 | $1.21M | Sell |
1,310,059
-962,086
| -42% | -$885K | ﹤0.01% | 3340 |
|
|
2022
Q1 | $4.07M | Buy |
2,272,145
+222,927
| +11% | +$399K | ﹤0.01% | 2918 |
|
|
2021
Q4 | $3.16M | Sell |
2,049,218
-81,904
| -4% | -$126K | ﹤0.01% | 3143 |
|
|
2021
Q3 | $4.33M | Buy |
2,131,122
+225,614
| +12% | +$458K | ﹤0.01% | 2995 |
|
|
2021
Q2 | $6.63M | Buy |
1,905,508
+1,051,301
| +123% | +$3.66M | ﹤0.01% | 2739 |
|
|
2021
Q1 | $1.52M | Buy |
854,207
+709,258
| +489% | +$1.26M | ﹤0.01% | 3387 |
|
|
2020
Q4 | $147K | Hold |
144,949
| – | – | ﹤0.01% | 3975 |
|
|
2020
Q3 | $150K | Buy |
144,949
+75,702
| +109% | +$78.3K | ﹤0.01% | 3803 |
|
|
2020
Q2 | $78K | Buy |
+69,247
| New | +$78K | ﹤0.01% | 3912 |
|